U.S. FDA allows abortion pills to be sold at retail pharmacies

Author of the article: Published Jan 03, 2023  •  Last updated 6 hours ago  •  3 minute read Join the conversation WASHINGTON — The U.S. Food and Drug Administration (FDA) will allow retail pharmacies to offer abortion pills in the United States for the first time, the agency said on Tuesday, even as more states seek…
U.S. FDA allows abortion pills to be sold at retail pharmacies

Author of the article:

Published Jan 03, 2023  •  Last updated 6 hours ago  •  3 minute read

Join the conversation

WASHINGTON — The U.S. Food and Drug Administration (FDA) will allow retail pharmacies to offer abortion pills in the United States for the first time, the agency said on Tuesday, even as more states seek to ban medication abortion.

The regulatory change will potentially expand abortion access as President Joe Biden’s administration wrestles with how best to protect abortion rights after they were sharply curtailed by the Supreme Court’s decision to overturn the landmark Roe v Wade ruling and the state bans that followed.

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails or any newsletter. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

Pharmacies can start applying for certification to distribute abortion pill mifepristone with one of the two companies that make it, and if successful they will be able to dispense it directly to patients upon receiving a prescription from a certified prescriber.

The FDA had first said it would be making those changes in December 2021 when it announced it would relax some risk evaluation and mitigation strategies, or REMS, on the pill, that had been in place since the agency approved it in 2000 and were lifted temporarily in 2021 due to the COVID-19 pandemic.

The changes included permanently removing restrictions on mail order shipping of the pills and their prescription through telehealth.

The agency finalized the changes on Tuesday after reviewing supplemental applications from Danco Laboratories and GenBioPro, the two companies that make the drug in the United States.

“Under the Mifepristone REMS Program, as modified, Mifeprex and its approved generic can be dispensed by certified pharmacies or by or under the supervision of a certified prescriber,” the agency said on its website on Tuesday.

Mifeprex is the brand name version of mifepristone which, in combination with a second drug called misoprostol that has various uses including miscarriage management, induces an abortion up to 10 weeks into a pregnancy in a process known as medication abortion.

Abortion rights activists say the pill has a long track record of being safe and effective, with no risk of overdose or addiction. In several countries, including India and Mexico, women can buy them without a prescription to induce abortion.

“Today’s news is a step in the right direction for health equity,” Planned Parenthood President Alexis McGill Johnson said in a statement.

“Being able to access your prescribed medication abortion through the mail or to pick it up in person from a pharmacy like any other prescription is a game changer for people trying to access basic health care,” Johnson added.

NO EQUAL ACCESS

The regulatory change will, however, not provide equal access to all people, GenBioPro, which makes the generic version of mifepristone, said in a statement.

Abortion bans, some targeting mifepristone, have gone into effect in more than a dozen states since the U.S. Supreme Court overturned the constitutional right to terminating pregnancies when it scrapped the 1973 Roe v. Wade ruling last year.

Women in those states could potentially travel to other states to obtain medication abortion.

The president of anti-abortion group SBA Pro-Life America, Marjorie Dannenfelser, said the latest FDA move endangers women’s safety and the lives of unborn children.

“State lawmakers and Congress must stand as a bulwark against the Biden administration’s pro-abortion extremism,” she said in a statement.

FDA records show a small mortality case number associated with mifepristone. As of June 2021, there were reports of 26 deaths linked with the pill out of 4.9 million people estimated to have taken it since it was approved in September 2000.

Retail pharmacies will have to weigh whether or not to offer the pill given the political controversy surrounding abortion, and determine where they can do so.

A spokesperson for CVS Health said the drugstore chain owner was reviewing the updated REMS “drug safety program certification requirements for mifepristone to determine the requirements to dispense in states that do not restrict the dispensing of medications prescribed for elective termination of pregnancy.”

A spokesperson for Walgreens, one of the largest U.S. pharmacies, said the company was also reviewing the FDA’s regulatory change. “We will continue to enable our pharmacists to dispense medications consistent with federal and state law.”

(Reporting by Ahmed Aboulenein; Additional reporting by Eric Beech in Washington, Shivani Tanna, Rahat Sandhu, and Kanjyik Ghosh in Bengaluru; Editing by Himani Sarkar)

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Germany to enter Phase 2 of emergency gas plan, says source
Read More

Germany to enter Phase 2 of emergency gas plan, says source

This advertisement has not loaded yet, but your article continues below. Author of the article: Article content BERLIN — Germany will enter Phase 2 of its three-stage emergency gas plan on Thursday, a source close to the matter told Reuters. The alarm stage, planned for when the government sees a high risk of long-term supply…
Russia Atomic Curbs Weighed by Biden Threaten Industry Upheaval
Read More

Russia Atomic Curbs Weighed by Biden Threaten Industry Upheaval

Author of the article: Bloomberg News Jonathan Tirone and Stephen Stapczynski (Bloomberg) — Sanctions targeting Moscow’s nuclear industry that are being weighed by the Biden administration are fraught with risk for European and U.S. utilities that rely on reactor fuel from Russia. The White House is considering sanctions on Russia’s state-owned atomic energy company, Rosatom…
COP27 delivers climate fund breakthrough at cost of progress on emissions
Read More

COP27 delivers climate fund breakthrough at cost of progress on emissions

Author of the article: Reuters Valerie Volcovici and Dominic Evans and William James Publishing date: Nov 20, 2022  •  14 hours ago  •  5 minute read Join the conversation * COP27 climate summit ends after marathon weekend negotiations Financial Post Top Stories Sign up to receive the daily top stories from the Financial Post, a division…
IMF to Cut Global Growth Outlook ‘Substantially’ at Next Review
Read More

IMF to Cut Global Growth Outlook ‘Substantially’ at Next Review

The International Monetary Fund will cut its global economic growth outlook “substantially” in its next update, as finance chiefs grapple with a shrinking list of options to address the worsening risks. Author of the article: Bloomberg News Yudith Ho and Michelle Jamrisko (Bloomberg) — The International Monetary Fund will cut its global economic growth outlook…